SCHEMBL4269558

SCHEMBL4269558

COCC(=O)N1CCC(NC(=O)C(=O)Nc2ccc(Cl)c(F)c2)C(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4269552 1.00
SCHEMBL12507952 0.93 RORC (0.36)
SCHEMBL1504205 0.89
SCHEMBL209318 0.89 FPR1 (0.43)
SCHEMBL4268432 0.88 EPHX2 (0.40)
SCHEMBL4268437 0.88 EPHX2 (0.40)
SCHEMBL209570 0.83
SCHEMBL6366563 0.83 UBE2M (0.40)
SCHEMBL4270359 0.81 F10 (0.40)
SCHEMBL4270362 0.81 F10 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281074-A1 DRUG COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING THROMBOSIS OR EMBOLISM DAIICHI PHARMACEUTICAL CO., LTD (JP) 2009-11-12 US disclosed
US-7576135-B2 Diamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-08-18 US disclosed
US-20060252837-A1 Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-11-09 US disclosed